PubRank

Guido Bondolfi

Author PubWeight™ 33.83‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 2002 3.31
2 Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry 2005 1.89
3 Lithium monitoring by reverse iontophoresis in vivo. Clin Chem 2004 1.47
4 Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode. Neuropsychobiology 2005 1.23
5 Genetic predictors of response to serotonergic and noradrenergic antidepressants in major depressive disorder: a genome-wide analysis of individual-level data and a meta-analysis. PLoS Med 2012 1.19
6 Possible induction of mania or hypomania by atypical antipsychotics: an updated review of reported cases. J Clin Psychiatry 2004 1.14
7 Screening for bipolar disorders using a French version of the Mood Disorder Questionnaire (MDQ). J Affect Disord 2005 1.00
8 Motivations to play specifically predict excessive involvement in massively multiplayer online role-playing games: evidence from an online survey. Eur Addict Res 2011 1.00
9 Early telephone intervention for psychiatric outpatients starting antidepressant treatment. Nord J Psychiatry 2010 0.99
10 The DEX/CRH neuroendocrine test and the prediction of depressive relapse in remitted depressed outpatients. J Psychiatr Res 2006 0.97
11 CYP2D6 and ABCB1 genetic variability: influence on paroxetine plasma level and therapeutic response. Ther Drug Monit 2008 0.95
12 Mindful Attention Awareness Scale (MAAS): Psychometric properties of the French translation and exploration of its relations with emotion regulation strategies. Psychol Assess 2009 0.94
13 The neural substrates of social emotion perception and regulation are modulated by adult attachment style. Soc Neurosci 2012 0.91
14 Quality of Web-based information on depression. Depress Anxiety 2010 0.90
15 Quality of web-based information on pathological gambling. J Gambl Stud 2008 0.89
16 Affective response to a loved one's pain: insula activity as a function of individual differences. PLoS One 2010 0.88
17 No human tryptophan hydroxylase-2 gene R441H mutation in a large cohort of psychiatric patients and control subjects. Biol Psychiatry 2006 0.87
18 Clinical and genetic correlates of suicidal ideation during antidepressant treatment in a depressed outpatient sample. Pharmacogenomics 2011 0.86
19 Is there a place for tricyclic antidepressants and subsequent augmentation strategies in obtaining remission for patients with treatment resistant depression? Pharmacol Res 2008 0.86
20 Influence of CRTC1 polymorphisms on body mass index and fat mass in psychiatric patients and the general adult population. JAMA Psychiatry 2013 0.85
21 Psychotropic drug-induced weight gain and other metabolic complications in a Swiss psychiatric population. J Psychiatr Res 2012 0.84
22 Cortisol responses to combined dexamethasone/CRH test in outpatients with a major depressive episode. J Psychiatr Res 2004 0.83
23 Salivary cortisol profiles in patients remitted from recurrent depression: one-year follow-up of a mindfulness-based cognitive therapy trial. J Psychiatr Res 2011 0.83
24 Pharmacogenetic study on risperidone long-acting injection: influence of cytochrome P450 2D6 and pregnane X receptor on risperidone exposure and drug-induced side-effects. J Clin Psychopharmacol 2013 0.82
25 Effects of emotional contexts on cerebello-thalamo-cortical activity during action observation. PLoS One 2013 0.81
26 Time course of response to paroxetine: influence of plasma level. Prog Neuropsychopharmacol Biol Psychiatry 2007 0.81
27 Does the form or the amount of exposure make a difference in the cognitive-behavioral therapy treatment of social phobia? J Nerv Ment Dis 2009 0.80
28 Assessment of mindfulness with the French version of the Kentucky Inventory of Mindfulness Skills in community and borderline personality disorder samples. Assessment 2010 0.79
29 The cortisol awakening response in patients remitted from depression. J Psychiatr Res 2010 0.79
30 Induction of a mixed depressive episode during rTMS treatment in a patient with refractory major depression. World J Biol Psychiatry 2006 0.77
31 Performance of the Mood Disorder Questionnaire (MDQ) according to bipolar subtype and symptom severity. Eur Psychiatry 2009 0.77
32 Fluoxetine augmentation in citalopram non-responders: pharmacokinetic and clinical consequences. Int J Neuropsychopharmacol 2000 0.76
33 Impact of HSD11B1 polymorphisms on BMI and components of the metabolic syndrome in patients receiving psychotropic treatments. Pharmacogenet Genomics 2015 0.76
34 Effects of expertise on football betting. Subst Abuse Treat Prev Policy 2012 0.75
35 Cognitive behaviour therapy reduces long term risk of relapse in recurrent major depressive disorder. Evid Based Ment Health 2005 0.75
36 [Depression: the mindfulness method, a new approach to relapse]. Rev Med Suisse 2013 0.75
37 [Mindfulness-based therapeutic approaches: benefits for individuals suffering from pain]. Rev Med Suisse 2012 0.75
38 [Actual therapeutic options in the treatment of generalized anxiety disorders]. Rev Med Suisse 2010 0.75
39 Venlafaxine versus applied relaxation for generalized anxiety disorder: a randomized controlled study on clinical and electrophysiological outcomes. Psychiatr Q 2015 0.75
40 [Treating depression: decision analysis for the general practitioner]. Rev Med Suisse 2012 0.75
41 Body dysmorphic disorder, psychosis and insight: a report of four cases. Psychopathology 2006 0.75